Home
Storia in 1 fonti
Morgan Stanley Sticks to Their Buy Rating for Innovent Biologics (IVBXF)
In a report released on May 28, from Morgan Stanley maintained a Buy rating on Innovent Biologics, with a price target of HK$135.00. The compan...
Raccontata da
markets.businessinsider.com
Timeline cronologica
- ·
Morgan Stanley Sticks to Their Buy Rating for Innovent Biologics (IVBXF)
In a report released on May 28, from Morgan Stanley maintained a Buy rating on Innovent Biologics, with a price target of HK$135.00. The compan...
- ·
CSC Financial Remains a Buy on Innovent Biologics (IVBXF)
CSC Financial analyst maintained a Buy rating on Innovent Biologics yesterday and set a price target of HK$147.70.Memorial Day Sale – Claim 55%...